Document is current
Any future updates will be listed below
-
Authors
McNamara, Katherine L. https://orcid.org/0000-0002-3717-6494
Caswell-Jin, Jennifer L. https://orcid.org/0000-0002-5711-8355
Joshi, Rohan https://orcid.org/0000-0003-0004-6466
Ma, Zhicheng
Kotler, Eran
Bean, Gregory R. https://orcid.org/0000-0003-2866-8283
Kriner, Michelle
Zhou, Zoey
Hoang, Margaret https://orcid.org/0000-0003-0442-855X
Beechem, Joseph
Zoeller, Jason
Press, Michael F.
Slamon, Dennis J.
Hurvitz, Sara A.
Curtis, Christina https://orcid.org/0000-0003-0166-3802
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F30CA239313, R01CA182514)
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 14 January 2021
Accepted: 3 March 2021
First Online: 8 April 2021
Competing interests
: M.F.P. received research funding from Cepheid, Eli Lilly and Company, Zymeworks and Novartis; performed consulting/advisory board work for Biocartis, Eli Lilly and Company, Zymeworks, Novartis, Puma Biotechnology, Merck Millipore, AstraZeneca, CME Outfitters and Clinical Care Options; and has private equity in TORL Biotherapeutics. D.J.S. received research funding from Pfizer, Novartis, Syndax, Millenium Pharmaceuticals, Aileron Therapeutics, Bayer and Genentech; owned stock in BioMarin, Amgen, Seattle Genetics and Pfizer; served on the board of directors for BioMarin; and performed consulting/advisory board work for Eli Lilly and Company, Novartis, Bayer and Pfizer. S.A.H. received contracted research and medical writing assistance from Ambrx, Amgen, Arvinas, Bayer, Daiichi Sankyo, Genentech/Roche, GlaxoSmithKline, Immunomedics, Eli Lilly and Company, Macrogenics, Novartis, Pfizer, OBI Pharma, Pieris, Puma Biotechnology, Radius Health, Sanofi, Seattle Genetics and Dignitana. R.J. is currently employed by Tempus. M.K., Z.Z., M.H. and J.B. are all employees of NanoString and declare that they have competing interests. C.C. performed advisory board/consulting work for Genentech, GRAIL, Illumina and NanoString and reports GRAIL stockholdings. C.C. and K.L.M. are coinventors on a patent application filed by Stanford University relating to this manuscript. J.L.C., Z.M., E.K., G.R.B. and J.Z. declare no conflicts of interest.
